Peel Hunt reaffirmed their buy rating on shares of Craneware (LON:CRW) in a research note issued to investors on Wednesday. The brokerage currently has a GBX 1,800 ($24.07) price target on the stock.

Separately, N+1 Singer reissued a hold rating on shares of Craneware in a research report on Tuesday, September 5th.

Shares of Craneware (LON:CRW) opened at GBX 1,530 ($20.46) on Wednesday. The company has a market capitalization of $411.39 and a price-to-earnings ratio of 4,250.00. Craneware has a 12-month low of GBX 1,165 ($15.58) and a 12-month high of GBX 1,885 ($25.20).

ILLEGAL ACTIVITY WARNING: “Peel Hunt Reaffirms Buy Rating for Craneware (CRW)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at

Craneware Company Profile

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Stock Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related stocks with our FREE daily email newsletter.